Organon (OGN) Revenue (2020 - 2026)

Organon (OGN) has reported Revenue for 7 consecutive years, with $1.5 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Revenue fell 3.5% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $6.2 billion (down 2.08% YoY), while the FY2025 annual figure was $6.2 billion, down 2.92% from the prior year.
• Revenue came in at $1.5 billion for Q1 2026 at Organon, down from $1.5 billion in the prior quarter.
• The five-year high for Revenue was $1.6 billion in Q1 2024, with the low at $1.5 billion in Q1 2026.
• Average Revenue over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2024.
• Across the five-year window, Revenue declined 7.36% in 2022 and advanced 7.61% in 2023, its largest moves.
• Year by year, Revenue stood at $1.5 billion in 2022, then increased by 7.61% to $1.6 billion in 2023, then slipped by 0.38% to $1.6 billion in 2024, then declined by 5.34% to $1.5 billion in 2025, then declined by 3.12% to $1.5 billion in 2026.
• According to Business Quant data, Revenue over the past three periods registered $1.5 billion, $1.5 billion, and $1.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.